Bleeding in early pregnancy
•
0 likes•37 views
This document contains a summary of topics related to early pregnancy complications and abortion. It lists bleeding in early pregnancy, ectopic pregnancy, risk factors and algorithms for diagnosis, methotrexate protocol, molar pregnancy symptoms and management, and habitual abortion as sections within the document. Contact information is provided for Dr. Tevfik Yoldemir as the author along with links to additional resources on these medical topics.
Report
Share
Report
Share
Download to read offline
Recommended
Extended field Radiotherapy with chemotherapy in treatment of cervical carcin...
Extended field Radiotherapy with chemotherapy in treatment of cervical carcinoma with retroperitoneal lymphadenopathy.
Kadın Sağlığında Yapay Zeka Uygulamaları.pdf
This document discusses various applications of artificial intelligence and machine learning in women's health, gynecology, and obstetrics. It provides an overview of supervised and unsupervised machine learning methods such as support vector machines, decision trees, linear regression, logistic regression, naive Bayes, random forests, K-means clustering, and Gaussian mixture modeling. It then discusses several disease applications, including using machine learning for breast cancer diagnosis and risk prediction, osteoporosis risk assessment and fracture prediction, predicting vasomotor symptoms, and using artificial intelligence to aid in the diagnosis of endometrial cancer, cervical dysplasia, and ovarian cancer. Numerous research studies applying these machine learning methods are cited.
ART options for poor responders.pdf
This document summarizes various ART options for poor ovarian responders. It discusses criteria for defining poor ovarian response, classification systems like POSEIDON, and studies comparing outcomes of different stimulation protocols. These include mild versus conventional stimulation, different gonadotropin doses and add-backs, natural cycles, estrogen priming, and supplements like DHEA, growth hormone, and CoQ10. Cumulative live birth rates are provided for various patient groups over multiple cycles, showing rates ranging from 12-75% depending on age and ovarian reserve.
ART for women over 40 years of age.pdf
The various stimulation protocols and cumulative birth rates for women over the age of 40 are discussed
Uterine Ageing.pdf
The uterine ageing affects endometrial receptivity, implantation, decidualization, and pregnancy outcomes. Animal and human in vitro studies are discussed. Donor egg program results in relation to recipients' age were compared between age groups.
Menopause Clinic.pdf
The document discusses managing menopause and lists its common symptoms such as hot flashes, sleep disturbances, mood changes, and vaginal dryness. It explains that symptoms are more likely during the menopause transition and after menopause as hormone levels decline. The document recommends primary care management of menopause and references algorithms and mobile apps that can help. It provides guidelines on assessing cardiovascular disease risk and reviewing various risk assessment tools.
Alternative Menopausal Hormone Therapies.pdf
This document discusses several alternative hormonal treatments for menopause symptoms. It summarizes data from clinical trials on the effects of ospemifene, bazedoxifene, tamoxifen, raloxifene, and prasterone (DHEA) on the endometrium, vagina, breast, bone and other tissues. It finds that these selective estrogen receptor modulators (SERMs) can reduce hot flashes and improve bone mineral density and sexual function symptoms, with neutral or protective effects on the breast and endometrium. Prasterone in particular is shown to significantly improve vaginal dryness, dyspareunia and other symptoms, without increasing serum estrogen, testosterone or DHEA levels
Recommended
Extended field Radiotherapy with chemotherapy in treatment of cervical carcin...
Extended field Radiotherapy with chemotherapy in treatment of cervical carcinoma with retroperitoneal lymphadenopathy.
Kadın Sağlığında Yapay Zeka Uygulamaları.pdf
This document discusses various applications of artificial intelligence and machine learning in women's health, gynecology, and obstetrics. It provides an overview of supervised and unsupervised machine learning methods such as support vector machines, decision trees, linear regression, logistic regression, naive Bayes, random forests, K-means clustering, and Gaussian mixture modeling. It then discusses several disease applications, including using machine learning for breast cancer diagnosis and risk prediction, osteoporosis risk assessment and fracture prediction, predicting vasomotor symptoms, and using artificial intelligence to aid in the diagnosis of endometrial cancer, cervical dysplasia, and ovarian cancer. Numerous research studies applying these machine learning methods are cited.
ART options for poor responders.pdf
This document summarizes various ART options for poor ovarian responders. It discusses criteria for defining poor ovarian response, classification systems like POSEIDON, and studies comparing outcomes of different stimulation protocols. These include mild versus conventional stimulation, different gonadotropin doses and add-backs, natural cycles, estrogen priming, and supplements like DHEA, growth hormone, and CoQ10. Cumulative live birth rates are provided for various patient groups over multiple cycles, showing rates ranging from 12-75% depending on age and ovarian reserve.
ART for women over 40 years of age.pdf
The various stimulation protocols and cumulative birth rates for women over the age of 40 are discussed
Uterine Ageing.pdf
The uterine ageing affects endometrial receptivity, implantation, decidualization, and pregnancy outcomes. Animal and human in vitro studies are discussed. Donor egg program results in relation to recipients' age were compared between age groups.
Menopause Clinic.pdf
The document discusses managing menopause and lists its common symptoms such as hot flashes, sleep disturbances, mood changes, and vaginal dryness. It explains that symptoms are more likely during the menopause transition and after menopause as hormone levels decline. The document recommends primary care management of menopause and references algorithms and mobile apps that can help. It provides guidelines on assessing cardiovascular disease risk and reviewing various risk assessment tools.
Alternative Menopausal Hormone Therapies.pdf
This document discusses several alternative hormonal treatments for menopause symptoms. It summarizes data from clinical trials on the effects of ospemifene, bazedoxifene, tamoxifen, raloxifene, and prasterone (DHEA) on the endometrium, vagina, breast, bone and other tissues. It finds that these selective estrogen receptor modulators (SERMs) can reduce hot flashes and improve bone mineral density and sexual function symptoms, with neutral or protective effects on the breast and endometrium. Prasterone in particular is shown to significantly improve vaginal dryness, dyspareunia and other symptoms, without increasing serum estrogen, testosterone or DHEA levels
Evaluation and Management of Endometriosis.pdf
The document discusses evaluation and management of endometriosis. It provides guidelines on suspecting and diagnosing endometriosis based on symptoms. Imaging techniques for diagnosing endometriosis are discussed, including transvaginal ultrasound and MRI. Surgical and medical treatments for endometriosis are covered. Risk of endometriosis recurrence after treatment and risk of endometriosis transforming into ovarian cancer are addressed. Emerging treatments using artificial intelligence and non-hormonal drugs are also mentioned.
Artificial Intelligence and Applications on Women's Health.pdf
Artificial Intelligence applications on Women's Health. Issues such as the prediction for bone loss, osteoporosis, stroke, myocardial infarction, ovarian cancer, endometrial cancer, cervical dysplasias and many more are discussed.
Management of menopausal symptoms for breast cancer survivors
This document summarizes management strategies for menopausal symptoms in breast cancer survivors. It discusses pharmacological options like clonidine, oxybutynin, antidepressants, black cohosh, and phytoestrogens. It also covers mind-body practices like cognitive behavioral therapy and hypnosis. Non-hormonal treatments for vulvo-vaginal symptoms are discussed, as well as short-term low dose local estrogen therapy. Management of menopausal symptoms requires a personalized approach balancing symptom relief and safety.
Health promotion for healthy aging
The World Health Organization (WHO) defined «healthy ageing»
as the process of developing and maintaining the functional ability
that enables wellbeing in older age. WHO describes this functional ability as being formed by interactions between intrinsic capacity and environmental characteristics.
The intrinsic capacity includes the mental and physical capacities of a person.
The environmental characteristics are related to home, community and society as a whole
Vulvar cancer
Vulvar cancer accounts for about 4% of gynecologic cancers. The most common type is squamous cell carcinoma, which typically affects women ages 65-75. Risk factors depend on whether the cancer is related to HPV infection or vulvar dystrophy. Treatment involves surgical excision, with laser ablation and wide local excision being main options. Topical imiquimod and 5-fluorouracil can also be used to treat preinvasive high-grade lesions. Long-term surveillance after treatment is important due to the risk of recurrence.
Vaginal cancer
Vaginal cancer is most commonly squamous cell carcinoma (SCC) and occurs most often in the 6th and 7th decades of life. Surgical excision is the main treatment for vaginal intraepithelial neoplasia (VAIN). Topical therapies like 5-fluorouracil cream or imiquimod cream can also be used, especially for multifocal disease not involving the lower vagina. Without treatment, 3% of VAIN 1 and 7% of VAIN 2/3 can progress to invasive cancer. Clinical presentation of vaginal cancer may include vaginal discharge, bleeding, urinary or gastrointestinal symptoms depending on location and involvement of nearby organs. Pretreatment evaluation includes examination, imaging, and biopsy
Prevention for cervial cancer
Cervical cancer and HPV infections can be prevented through vaccination and other behavioral interventions. There are two FDA approved vaccines that are effective at preventing HPV infection and cervical lesions caused by HPV types 16 and 18. The vaccines stimulate strong immune responses to the virus-like particles of HPV without being infectious. Vaccination is recommended for girls ages 11-12, or ages 13-26 before sexual debut. Screening is still important as the vaccines do not protect against all HPV types that can cause cervical cancer.
Female sexual function dysfunction
This document discusses various aspects of female sexual function and dysfunction, including physiology, models of sexual response, phases of sexual response, and instruments used to assess female sexual dysfunction. It provides details on several validated questionnaires used to evaluate female sexual function, including the Female Sexual Function Index, Changes in Sexual Functioning Questionnaire, Derogatis Interview for Sexual Functioning, and Sexual Quality of Life-Female Questionnaire. It also discusses components of clinical evaluation for female sexual dysfunction, such as history, physical exam, lab tests, and treatment options.
Urinary incontinence
Urinary incontinence is the involuntary loss of urine and can range from mild dribbling to severe leakage. It affects up to 20% of older adults and 50% of nursing home residents, with prevalence increasing with age. The main types are stress, urge, overflow, and functional incontinence. Treatment includes behavioral modifications like pelvic floor exercises, pharmacotherapy with medications like anticholinergics and alpha-agonists, injections, surgery such as slings and colposuspensions, and devices like pessaries. Behavioral treatments aim to strengthen pelvic floor muscles or modify bladder habits while medications and surgeries treat underlying causes.
Pelvic organ prolapse
The document provides an overview of pelvic floor anatomy and pelvic organ prolapse. It discusses the structures that support the pelvic organs, including the levator ani muscles, endopelvic fascia, and pelvic ligaments. Common types of pelvic organ prolapse are described such as cystocele, rectocele, and uterine prolapse. The document outlines how these defects are evaluated based on their location and stage. Treatment options are also summarized, including pelvic floor muscle exercises, pessaries, and various surgical repair techniques aimed at reconstructing the pelvic floor.
Infertility workup
This document provides an overview of infertility, including definitions, causes, evaluation, and treatment options. It discusses the main factors that can contribute to infertility such as ovulation disorders, male factor issues, tubal damage, and endometriosis. Evaluation involves testing for both male and female partners. Treatment options range from lifestyle changes and ovulation induction to assisted reproductive technologies like IUI, IVF, and ICSI depending on the diagnosis. IVF is described in detail including the stimulation, retrieval, laboratory, transfer, and outcome monitoring processes. Special issues like PGD and egg donation are also reviewed.
Hirsutism
This document discusses hirsutism, defined as excessive hair growth in androgen-dependent areas. It covers the physiology of hair growth and androgens, etiologies including PCOS and adrenal/ovarian tumors, diagnosis via Ferriman-Gallway scoring and lab tests, and treatments such as oral contraceptives, GnRH agonists, and androgen receptor antagonists like spironolactone and cyproterone acetate.
Female genital cancer screening
This document summarizes screening methods for female reproductive tract cancers. It discusses screening for cancers of the vulva, vagina, cervix, endometrium, tubes, and ovaries. Screening methods include the Pap test for cervical cancer screening, as well as screening high-risk groups for ovarian cancer. The document provides details on Pap test procedures, accuracy, limitations, and screening guidelines for adolescents and immune compromised patients.
Dysfunctional uterine bleeding
Dysfunctional uterine bleeding can present as irregular bleeding, severe acute bleeding, or menorrhagia. The document recommends treating irregular bleeding with a combination oral contraceptive pill or cyclic progestin therapy for at least 3 months to regulate the cycle. Menorrhagia can be treated by starting an oral contraceptive on the first day of menstruation. Progestin therapy involves using medroxyprogesterone 10-20 mg daily for 14 days, then off for 14 days, and cycling in this way. Nonsteroidal anti-inflammatory drugs or hormonal therapy are also recommended for treating menorrhagia.
Cervical precancerous lesions and cervical cancer
Human papillomavirus (HPV) infection is the primary cause of cervical cancer. Risk factors include multiple sexual partners, young age of first intercourse, smoking, and immunosuppression. Abnormal pap smears may indicate cervical dysplasia and require colposcopy and biopsy. Precancerous lesions have potential to regress, persist, or progress to cancer over time. Screening via pap testing aims to detect early changes for treatment before cancer develops.
Pelvic Organ Prolapse and anatomical landmarks
The document discusses pelvic organ prolapse from an anatomical perspective. It describes the layers of fascia and muscles that provide support to the pelvic organs. Damage to the fascia can result in cystocele, rectocele, or uterine prolapse as the pelvic organs lose support and protrude into the vaginal canal. The document outlines the components of the pelvic floor according to the Integral Theory and how dysfunction, such as stress urinary incontinence, can arise from weakness or damage in specific areas. Assessment tools like the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire are also mentioned for evaluating patients.
IVF treatment for endometriosis patients
The document discusses various studies on endometriosis and its relationship to in vitro fertilization (IVF) outcomes. It summarizes findings from multiple studies on topics such as live birth rates, clinical pregnancy rates, oocyte retrieval outcomes, and miscarriage rates for patients with endometriosis undergoing IVF compared to control groups without endometriosis. It also summarizes studies comparing IVF outcomes based on the severity of endometriosis, location of endometriotic lesions, and whether endometriomas were treated surgically prior to IVF.
Acute Gout Care & Urate Lowering Therapy .pdf
In this document , the management of acute gout attacks and a description of urate lowering therapy is mentioned.
More Related Content
More from Marmara University School of Medicine
Evaluation and Management of Endometriosis.pdf
The document discusses evaluation and management of endometriosis. It provides guidelines on suspecting and diagnosing endometriosis based on symptoms. Imaging techniques for diagnosing endometriosis are discussed, including transvaginal ultrasound and MRI. Surgical and medical treatments for endometriosis are covered. Risk of endometriosis recurrence after treatment and risk of endometriosis transforming into ovarian cancer are addressed. Emerging treatments using artificial intelligence and non-hormonal drugs are also mentioned.
Artificial Intelligence and Applications on Women's Health.pdf
Artificial Intelligence applications on Women's Health. Issues such as the prediction for bone loss, osteoporosis, stroke, myocardial infarction, ovarian cancer, endometrial cancer, cervical dysplasias and many more are discussed.
Management of menopausal symptoms for breast cancer survivors
This document summarizes management strategies for menopausal symptoms in breast cancer survivors. It discusses pharmacological options like clonidine, oxybutynin, antidepressants, black cohosh, and phytoestrogens. It also covers mind-body practices like cognitive behavioral therapy and hypnosis. Non-hormonal treatments for vulvo-vaginal symptoms are discussed, as well as short-term low dose local estrogen therapy. Management of menopausal symptoms requires a personalized approach balancing symptom relief and safety.
Health promotion for healthy aging
The World Health Organization (WHO) defined «healthy ageing»
as the process of developing and maintaining the functional ability
that enables wellbeing in older age. WHO describes this functional ability as being formed by interactions between intrinsic capacity and environmental characteristics.
The intrinsic capacity includes the mental and physical capacities of a person.
The environmental characteristics are related to home, community and society as a whole
Vulvar cancer
Vulvar cancer accounts for about 4% of gynecologic cancers. The most common type is squamous cell carcinoma, which typically affects women ages 65-75. Risk factors depend on whether the cancer is related to HPV infection or vulvar dystrophy. Treatment involves surgical excision, with laser ablation and wide local excision being main options. Topical imiquimod and 5-fluorouracil can also be used to treat preinvasive high-grade lesions. Long-term surveillance after treatment is important due to the risk of recurrence.
Vaginal cancer
Vaginal cancer is most commonly squamous cell carcinoma (SCC) and occurs most often in the 6th and 7th decades of life. Surgical excision is the main treatment for vaginal intraepithelial neoplasia (VAIN). Topical therapies like 5-fluorouracil cream or imiquimod cream can also be used, especially for multifocal disease not involving the lower vagina. Without treatment, 3% of VAIN 1 and 7% of VAIN 2/3 can progress to invasive cancer. Clinical presentation of vaginal cancer may include vaginal discharge, bleeding, urinary or gastrointestinal symptoms depending on location and involvement of nearby organs. Pretreatment evaluation includes examination, imaging, and biopsy
Prevention for cervial cancer
Cervical cancer and HPV infections can be prevented through vaccination and other behavioral interventions. There are two FDA approved vaccines that are effective at preventing HPV infection and cervical lesions caused by HPV types 16 and 18. The vaccines stimulate strong immune responses to the virus-like particles of HPV without being infectious. Vaccination is recommended for girls ages 11-12, or ages 13-26 before sexual debut. Screening is still important as the vaccines do not protect against all HPV types that can cause cervical cancer.
Female sexual function dysfunction
This document discusses various aspects of female sexual function and dysfunction, including physiology, models of sexual response, phases of sexual response, and instruments used to assess female sexual dysfunction. It provides details on several validated questionnaires used to evaluate female sexual function, including the Female Sexual Function Index, Changes in Sexual Functioning Questionnaire, Derogatis Interview for Sexual Functioning, and Sexual Quality of Life-Female Questionnaire. It also discusses components of clinical evaluation for female sexual dysfunction, such as history, physical exam, lab tests, and treatment options.
Urinary incontinence
Urinary incontinence is the involuntary loss of urine and can range from mild dribbling to severe leakage. It affects up to 20% of older adults and 50% of nursing home residents, with prevalence increasing with age. The main types are stress, urge, overflow, and functional incontinence. Treatment includes behavioral modifications like pelvic floor exercises, pharmacotherapy with medications like anticholinergics and alpha-agonists, injections, surgery such as slings and colposuspensions, and devices like pessaries. Behavioral treatments aim to strengthen pelvic floor muscles or modify bladder habits while medications and surgeries treat underlying causes.
Pelvic organ prolapse
The document provides an overview of pelvic floor anatomy and pelvic organ prolapse. It discusses the structures that support the pelvic organs, including the levator ani muscles, endopelvic fascia, and pelvic ligaments. Common types of pelvic organ prolapse are described such as cystocele, rectocele, and uterine prolapse. The document outlines how these defects are evaluated based on their location and stage. Treatment options are also summarized, including pelvic floor muscle exercises, pessaries, and various surgical repair techniques aimed at reconstructing the pelvic floor.
Infertility workup
This document provides an overview of infertility, including definitions, causes, evaluation, and treatment options. It discusses the main factors that can contribute to infertility such as ovulation disorders, male factor issues, tubal damage, and endometriosis. Evaluation involves testing for both male and female partners. Treatment options range from lifestyle changes and ovulation induction to assisted reproductive technologies like IUI, IVF, and ICSI depending on the diagnosis. IVF is described in detail including the stimulation, retrieval, laboratory, transfer, and outcome monitoring processes. Special issues like PGD and egg donation are also reviewed.
Hirsutism
This document discusses hirsutism, defined as excessive hair growth in androgen-dependent areas. It covers the physiology of hair growth and androgens, etiologies including PCOS and adrenal/ovarian tumors, diagnosis via Ferriman-Gallway scoring and lab tests, and treatments such as oral contraceptives, GnRH agonists, and androgen receptor antagonists like spironolactone and cyproterone acetate.
Female genital cancer screening
This document summarizes screening methods for female reproductive tract cancers. It discusses screening for cancers of the vulva, vagina, cervix, endometrium, tubes, and ovaries. Screening methods include the Pap test for cervical cancer screening, as well as screening high-risk groups for ovarian cancer. The document provides details on Pap test procedures, accuracy, limitations, and screening guidelines for adolescents and immune compromised patients.
Dysfunctional uterine bleeding
Dysfunctional uterine bleeding can present as irregular bleeding, severe acute bleeding, or menorrhagia. The document recommends treating irregular bleeding with a combination oral contraceptive pill or cyclic progestin therapy for at least 3 months to regulate the cycle. Menorrhagia can be treated by starting an oral contraceptive on the first day of menstruation. Progestin therapy involves using medroxyprogesterone 10-20 mg daily for 14 days, then off for 14 days, and cycling in this way. Nonsteroidal anti-inflammatory drugs or hormonal therapy are also recommended for treating menorrhagia.
Cervical precancerous lesions and cervical cancer
Human papillomavirus (HPV) infection is the primary cause of cervical cancer. Risk factors include multiple sexual partners, young age of first intercourse, smoking, and immunosuppression. Abnormal pap smears may indicate cervical dysplasia and require colposcopy and biopsy. Precancerous lesions have potential to regress, persist, or progress to cancer over time. Screening via pap testing aims to detect early changes for treatment before cancer develops.
Pelvic Organ Prolapse and anatomical landmarks
The document discusses pelvic organ prolapse from an anatomical perspective. It describes the layers of fascia and muscles that provide support to the pelvic organs. Damage to the fascia can result in cystocele, rectocele, or uterine prolapse as the pelvic organs lose support and protrude into the vaginal canal. The document outlines the components of the pelvic floor according to the Integral Theory and how dysfunction, such as stress urinary incontinence, can arise from weakness or damage in specific areas. Assessment tools like the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire are also mentioned for evaluating patients.
IVF treatment for endometriosis patients
The document discusses various studies on endometriosis and its relationship to in vitro fertilization (IVF) outcomes. It summarizes findings from multiple studies on topics such as live birth rates, clinical pregnancy rates, oocyte retrieval outcomes, and miscarriage rates for patients with endometriosis undergoing IVF compared to control groups without endometriosis. It also summarizes studies comparing IVF outcomes based on the severity of endometriosis, location of endometriotic lesions, and whether endometriomas were treated surgically prior to IVF.
More from Marmara University School of Medicine (20)
Artificial Intelligence and Applications on Women's Health.pdf
Artificial Intelligence and Applications on Women's Health.pdf
Management of menopausal symptoms for breast cancer survivors
Management of menopausal symptoms for breast cancer survivors
Recently uploaded
Acute Gout Care & Urate Lowering Therapy .pdf
In this document , the management of acute gout attacks and a description of urate lowering therapy is mentioned.
Histololgy of Female Reproductive System.pptx
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
PGx Analysis in VarSeq: A User’s Perspective
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...ayushrajshrivastava7
Regulatory Affairs
Full hand written notes
M.pharm - 1st year .Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
Know the difference between Endodontics and Orthodontics.
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
une 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Patellar Instability: Diagnosis Management
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Do you have abnormal smell after periods? It may be vaginitis. Do not worry, herbal medicine Fuyan Pill can help you get a cure.
What is Obesity? How to overcome Obesity?
Obesity is a chronic complex disease defined by excessive fat deposits that can impair health.
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Fallopian tube blockage may cause female infertility. For treatment, herbal medicine Fuyan Pill can be a solution.
Recently uploaded (20)
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Bleeding in early pregnancy
- 1. 20.06.2018 1 Bleeding in early pregnancy Tevfik Yoldemir MD BSc MA www.yoldemir.com Ectopicpregnancy Risk factors Algorithmfor diagnosisof EP -1 Algorithmfor diagnosisof EP -2 MTXprotocol
- 2. 20.06.2018 2 Initiationof MTX Candidatesfor MTX treatment Molarpregnancy Presentingsymptoms Postmolar gestational trophoblasticdisease Algorithm for molar pregnancymanagement
- 4. 20.06.2018 4 Summary Q & A www.slideshare.net/dryoldemir tevfik.yoldemir@marmara.edu.tr